{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,7,5]],"date-time":"2023-07-05T04:22:54Z","timestamp":1688530974616},"reference-count":14,"publisher":"Baishideng Publishing Group Inc.","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["World J Gastrointest Pharmacol Ther"],"DOI":"10.4292\/wjgpt.v14.i4.33","type":"journal-article","created":{"date-parts":[[2023,7,4]],"date-time":"2023-07-04T06:54:30Z","timestamp":1688453670000},"page":"33-38","source":"Crossref","is-referenced-by-count":0,"title":["Hepatitis C virus treatment with glecaprevir and pibrentasvir in patients co-prescribed carbamazepine: Three case reports"],"prefix":"10.4292","volume":"14","author":[{"given":"Michael","family":"Braude","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dilip T","family":"Ratnam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Louise","family":"Marsh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua H","family":"Abasszade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anouk T","family":"Dev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2060","published-online":{"date-parts":[[2023,7,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eplepsyres.2011.02.012"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-012-6509-3"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2018.03.026"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1111\/cts.13471"},{"key":"B5","unstructured":"Administration AGDooHTG.   Australian Public Assessment Report for Glecaprevir\/pibrentasvir. 2018. [cited 10 February 2023]. Available from: https:\/\/www.tga.gov.au\/sites\/default\/files\/auspar-glecaprevir-pibrentasvir-181106.pdf"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2016.07.002"},{"key":"B7","unstructured":"European Medicines Agency.   Summary of product characteristics. [cited 20 June 2022]. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/sovaldi-epar-product-information_en.pdf"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2018.10.010"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1177\/0897190020977762"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2021.05.040"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.4254\/wjh.v9.i33.1239"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02558-16"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01620-17"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29081"}],"container-title":["World Journal of Gastrointestinal Pharmacology and Therapeutics"],"original-title":[],"link":[{"URL":"https:\/\/www.wjgnet.com\/2150-5349\/full\/v14\/i4\/33.htm","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.wjgnet.com\/2150-5349\/full\/v14\/i4\/33.htm","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,4]],"date-time":"2023-07-04T06:54:33Z","timestamp":1688453673000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.wjgnet.com\/2150-5349\/full\/v14\/i4\/33.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,5]]},"references-count":14,"journal-issue":{"issue":"4"},"URL":"https:\/\/doi.org\/10.4292\/wjgpt.v14.i4.33","relation":{},"ISSN":["2150-5349"],"issn-type":[{"value":"2150-5349","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7,5]]}}}